EU and Industry Join Forces to Invest €22 Billion in Research and Innovation

The European Commission, EU Member States and European industry will invest more than €22 billion over the next seven years in innovation for sectors that deliver high quality jobs. Most of the investment will go to five public-private partnerships in innovative medicines, aeronautics, bio-based industries, fuel cells and hydrogen, and electronics. These research partnerships will boost the competitiveness of EU industry in sectors that already provide more than 4 million jobs. They will also find solutions to major challenges for society that are not being solved quickly enough by the market alone, such as reducing carbon emissions or providing the next generation of antibiotics. The package also proposes to extend an initiative to pool research and innovation investments in Air Traffic Management (SESAR), in support of the Single European Sky.

José Manuel Barroso, President of the European Commission, said: "The EU must remain a leader in strategic global technology sectors that provide high quality jobs. This innovation investment package combines public and private funding to do just that. This is a perfect demonstration of the leverage effect of the EU budget for growth and jobs."

Overall, a proposed €8 billion investment from the next EU research and innovation programme, Horizon 2020, will secure around €10 billion from industry, and close to €4 billion from EU Member States.

European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said: "These initiatives not only strengthen our economy, they are an investment in a better quality of life. Working together will enable us to tackle issues that no one company or country can deal with alone."

The five Public-Private Partnerships, called 'Joint Technology Initiatives' (JTIs), are:

  • Innovative Medicines 2 (IMI2): to develop next generation vaccines, medicines and treatments, such as new antibiotics
  • Fuel Cells and Hydrogen 2 (FCH2): to expand the use of clean and efficient technologies in transport, industry and energy
  • Clean Sky 2 (CS2): to develop cleaner, quieter aircraft with significantly less CO2 emissions
  • Bio-based Industries (BBI): to use renewable natural resources and innovative technologies for greener everyday products
  • Electronic Components and Systems (ECSEL): to boost Europe’s electronics manufacturing capabilities

The JTIs are open to a wide range of industries across Europe, including SMEs, and all types of research organisations can apply for funding. The Commission has developed the new initiatives in close partnership with industry, who in turn have committed substantial financial resources. Major changes have been introduced to address the criticisms that the current initiatives are overly complex and difficult to participate in.

The Innovative Medicines Initiative, Clean Sky and Fuel Cells and Hydrogen JTIs all currently exist, while the Electronics JTI will combine two current partnerships. The Bio-based Industries JTI is a new initiative. New legislative proposals are needed now to establish the initiatives under the next EU research and innovation programme, Horizon 2020, which is subject to approval by the European Parliament and Council.

The package also includes four public-public partnerships between the European Commission and EU Member States: new treatments against poverty-related diseases, measurement technologies for industrial competitiveness, support for high tech SMEs, and solutions for the elderly and disabled to live safely in their homes.

The Commission Communication accompanying the legislative proposals also sets out how the Commission intends to strengthen industrial engagement in Horizon 2020 through further public-private partnerships, such as in the areas of Green Cars, Energy Efficient Buildings, Factories of the Future, Sustainable Process Industries, Robotics and Photonics.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...